News Releases

04/06/20	Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)
03/11/20	Millendo Therapeutics Reports Full Year 2019 Operating and Financial Results
03/05/20	Millendo Therapeutics to Present at Upcoming Investor Conferences
02/18/20	Millendo Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
02/10/20	Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
01/09/20	Millendo Therapeutics Promotes Thomas Hoover to Chief Commercial Officer

News Releases

Shareholder Tools